• Sildenafil Citrate: Deciphering Proteoform-Specific Signa...

  2025-09-23

  Explore how Sildenafil Citrate, a selective cGMP-specific phosphodiesterase type 5 inhibitor, enables advanced research into proteoform-specific signaling, vascular smooth muscle relaxation, and apoptosis regulation. This article highlights emerging strategies for integrating proteomics and small-molecule pharmacology to elucidate PDE5-related pathways.

• S63845: Targeting MCL1 to Unlock Synergistic Apoptosis Pa...

  2025-09-22

  This article explores the mechanistic synergy between the small molecule MCL1 inhibitor S63845 and extrinsic apoptosis modulators, highlighting its role as a mitochondrial apoptotic pathway activator in cancer research. Focus is placed on recent data supporting combinatorial strategies and on practical considerations for hematological and solid tumor models.

• BMN 673 (Talazoparib): Advancing PARP1/2 Inhibitor Resear...

  2025-09-19

  Explore the latest insights into BMN 673 (Talazoparib), a potent PARP1/2 inhibitor, and its unique role in targeting DNA repair deficiencies and homologous recombination-deficient cancers. This article discusses new mechanistic findings and research applications for selective PARP inhibitors in cancer therapy.

• Phenacetin in Human Intestinal Organoid Models: Research ...

  2025-09-18

  Explore the use of Phenacetin (N-(4-ethoxyphenyl)acetamide), a non-opioid analgesic, in advanced pharmacokinetic studies utilizing human intestinal organoids. This article discusses scientific research applications, solubility characteristics, and safety considerations for Phenacetin.

• br Hyperadiponectinemia in disease conditions Other evidence

  2025-03-03

  

  Hyperadiponectinemia in disease conditions Other evidence indicates that hyperadiponectinemia does not necessarily always imply a healthy outcome. Indeed, a recent study suggested that hyperadiponectinemia occurs in various diseases. Given that the risk for AD and vascular dementia is increased i

• hydroxydopamine OHDA is a selective catecholaminergic neurot

  2025-03-03

  

  6-hydroxydopamine (6-OHDA) is a selective catecholaminergic neurotoxin mainly used to generate lesions in the nigrostriatal pathway in rats (Ungerstedt, 1968). The most common use of 6-OHDA is via unilateral injection into the rat medial forebrain bundle (MFB). DA depletion, nigral DA cell loss, and

• br Experimental section br Conflicts

  2025-03-03

  

  Experimental section Conflicts of interest Acknowledgments This work was partly supported by INSA-Rouen, Rouen University, CNRS, Labex SynOrg (ANR-11-LABX-0029), Région Haute-Normandie. Introduction A key component of the integrated management of key pests such as codling moth (Cydia po

• An alternative to the agonist or antagonist potential in

  2025-03-03

  

  An alternative to the agonist or antagonist potential in drug discovery is the positive allosteric modulator (PAM) approach, which can augment the normal processes of neurotransmission as opposed to directly replacing or antagonizing them. PAMs are thought to bind to sites that are distinct from the

• The small fishers with little or

  2025-03-03

  

  The small fishers with little or no quota who remained relied on quota leasing arrangements to continue their fishing operations. Such arrangements had relatively high transaction costs and by early 2000 it appeared that the demise of the small fisher was imminent [2]. The introduction in 2001 of t

• It has been reported that leukotrienes and

  2025-03-03

  

  It has been reported that leukotrienes and their receptors, e.g. the cysteinyl leukotriene receptor 1 (CysLT1) may promote EGFR Inhibitor mg injury (Ding et al., 2007) and that increased 5-LOX expression and activity lead to production of brain-toxic molecules (Khan et al., 2010). However, differen

• Additionally regulation of GPCR heteromerization by specific

  2025-03-03

  

  Additionally, regulation of GPCR heteromerization by specific ligands may depend not only on the affinity of ligands for receptors, but also on presence of different interacting proteins co-localizing with the receptors in the specific cell, which may induce some conformational changes and contribut

• br Viral manipulation of host factors to

  2025-03-03

  

  Viral manipulation of host factors to oppose anti-viral autophagy To escape or manipulate autophagy, some viruses developed strategies that are based on the recruitment of host-cell endogenous factors. The non-enveloped double-stranded DNA virus adenovirus is rapidly endocytosed after attachment.

• With regard to the first question subcellular fractionation

  2025-03-01

  

  With regard to the first question, subcellular fractionation studies revealed that BDK and PPM1K are clearly detectable in both the mitochondrial and cytosolic subcellular fractions, thus making it possible for these enzymes to interact with both the BCKDH and ACL substrates. The preferential presen

• br Materials and methods br Results br Discussion

  2025-03-01

  

  Materials and methods Results Discussion Many studies investigate the role of 12/15-LOX in cancer cell,23, 24, 25 however we here first found that host 12/15-LOX also plays an important role in metastasis progression. We have demonstrated that 12(S)-HETE increased melanoma cell adhesion to

• Based on the extracellular domain structures

  2025-03-01

  

  Based on the extracellular domain structures, we can infer that the dimer arrangement of GABAB receptor will undergo substantial changes upon receptor activation (Geng et al., 2013). First, agonist-stimulated closure of GABAB1 VFT would cause an upward rotation of its LB2 domain, coupled with an inw

15951 records 1/1064 page Next 12345 下5页 Last page